I bought a big position 2 weeks ago for several reasons. First, the market cap is half the value of the net cash position, so the stock is basically being given away at current price. Second, the data on eravacycline is very strong in terms of its ability to kill MDR bacteria. The recently discovered strain of CRE E Coli that is also colistin resistant would very likely be sensitive to eravacycline. The need for a new antibiotic to deal with drug resistance is high.
We know this drug works clinically, it passed th cIAI trial. It failed the cUTI, but that was in my view because it was being compared with very potent quinolone and they stepped therapy down to oral instead of treating IV for the entire course. If the trial was done on patients with high rates of quinolone resistant infections, it would have been superior. I think the risk reward here is quite good, and the stock could easily double over the next year.
Just as a matter of the actual facts, Facebook is not censoring private posts. Facebook has a news feed service that pops up on your page if you are interested in that sort of thing. There is a group that determines what articles get posted to that feed. An ex-employee that claimed to have worked there made an anonymous claim that news articles that support "conservative" viewpoints are routinely prevented from being included in that news feed. Whether that is actually true or not has not been shown.